Purple Biotech Ltd. Sponsored ADR PPBT
1.49
0.01
0.68%
as of 25 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow PPBT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| P/E ratio | — | — | — | — |
+8 more quarters Free account |
| EV/Sales | — | — | — | — | |
| EV/FCF | — | — | — | — | |
| Quick Ratio | 3.42 | 1.40 | 1.23 | 1.73 | |
| Current Ratio | 3.70 | 1.48 | 1.27 | 1.78 | |
| Net Debt/EBITDA | 4.97 | 2.94 | 0.41 | 7.99 | |
| Debt/Assets | 0.00% | 0.00% | 0.00% | 0.00% | |
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating CF/Net income | (5.68) | 36.29 | 0.05 | 0.82 | |
| Capex/Depreciation | (0.04) | 0.00 | (0.17) | 0.14 | |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | |
| Research and Development Expense of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Selling, General and Administrative Expense of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Intangible Assets out of Total Assets | 0.52 | 0.51 | 0.42 | 0.71 | |
| Share Based Compensation of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Free Cash Flow Yield | — | — | — | — | |
| Revenue per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating CF per Share | (2.30) | (3.35) | (2.22) | (2.34) | |
| Capex per Share | 0.00 | 0.00 | (0.02) | 0.02 | |
| Free Cash Flow per Share | (2.31) | (3.35) | (2.24) | (2.32) | |
| Cash per Share | 5.62 | 6.90 | 19.94 | 22.95 | |
| Shareholders Equity per Share | 11.25 | 10.38 | 20.12 | 72.04 | |
| Interest Debt per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book value per Share | 11.25 | 10.38 | 20.12 | 72.04 | |
| Free Cash Flow | (2.51) | (3.12) | (1.08) | (1.06) | |
| Working Capital | 4.81 | 2.19 | 2.11 | 4.72 | |
| Capital Expenditures | 0.00 | — | (0.01) | 0.01 | |
| Net Current Asset Value | 4.64 | 2.03 | 1.95 | 4.53 | |
| EV/EBIT | — | — | — | — | |
| Capex to Sales | 0.00 | — | 0.00 | 0.00 | |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
| Average Payables | 0.58 | 0.86 | 1.76 | 1.26 | |
| Average Assets | 24.27 | 25.01 | 27.31 | 37.08 | |
| Average Common Equity | 22.13 | 21.18 | 21.29 | 31.14 |
Columns are period end dates